Lilly is a global health care leader that unites caring with discovery to create medicines that make life better for people around the world. It was founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today it remains true to that mission in all its work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
Financial Statements
- Click here to download Lilly(Eli) & Co's Income Statement
- Click here to download Lilly(Eli) & Co's Balance Sheet
- Click here to download Lilly(Eli) & Co's Statement of Cash Flows
Key Info
- Industry: Pharmaceutical Preparation Manufacturing
- Sector: Manufacturing
- CEO Name: David Ricks
Key Statistics
- Stock Price: $249.95
- Dividend Yield: 1.4000000000000001%
- Market Capitalization: $238,896,276,557
- Shares Outstanding: 952,347,126
- Number of Employees: 2,020
- Trailing 12-Month EPS: $6.12
- Trailing 12-Month DPS: $3.51
- Payout Ratio: 57.4%
Important Dates
- Next Earnings Date: 2022-04-28
- Next Ex-Dividend Date: 2022-02-14
Price Trends
- Current Stock Price: $249.95
- 52-week high: $282.72
- 52-week low: $175.91
- 200-day moving average: $249.02
- 50-day moving average: $243.52
Performance
- 1-Month Price Return: 6.4%
- 3-Month Price Return: -3.3%
- 6-Month Price Return: -2.7%
- 1-Year Price Return: 24.3%
- 2-Year Price Return: 100.9%
- 5-Year Price Return: 235.5%
Visit the Passiv Stock Directory
Data provided by IEX Cloud
For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast